← FDA Drug Approvals (Drugs@FDA)

RYBREVANT

BLA · Biologics License Application · Sponsor: JANSSEN BIOTECH · Approved 2021-05-21

Drug application

FDA Application #

BLA761210

Application type

Biologics License Application

Brand name

RYBREVANT

Generic name

AMIVANTAMAB-VMJW

Active ingredients

AMIVANTAMAB-VMJW

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

JANSSEN BIOTECH

Manufacturer

Janssen Biotech, Inc.

First approval

2021-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown